Maine Cannabis: 179 Stores, 100% Capture, and the Tourism Correction

Maine operates the highest-priced full-capture legal market in the dataset. At $6.38/g pre-tax — above Nevada, Rhode Island, and Illinois — the state still achieves complete resident black market displacement. The more instructive story is what happens when 13 million annual tourists inflate sales figures in a small-population state, and why naive TAM calculations for seasonal markets overstate capture rates.

Market Overview

Maine legalized adult-use cannabis under Question 1 in November 2016. First recreational retail sales launched October 9, 2020 after a multi-year implementation delay. The market is regulated by the Office of Cannabis Policy (OCP).

Key metrics:

• 179 active retail stores statewide
• 2024 combined revenue: $512.9 million ($269.0M medical + $243.9M adult-use)
• $6.38/g adult-use flower (2024, pre-tax; OCP open data)
• 18.7% total tax burden (per-pound excise + 10% sales tax)
• ~100% estimated resident capture plus ~12.5% tourism premium
• $2.87M revenue per store annually
• 6 mature plants per adult home cultivation permitted

Flower Pricing

Maine is the highest-priced market in the dataset that still achieves full resident capture. At $7.57/g out the door, Maine's legal cannabis sits at the upper edge of the regional black market range ($5–8/g) rather than comfortably below it. That it achieves 100% capture at this price point — while Rhode Island at $6.80 captures only 39% and Illinois at $8.13 captures 30% — is the key data point. Price matters, but it doesn't operate in isolation from enforcement and access.

Rhode Island at $6.80 captures 39%. Maine at $7.57 captures 100%. The $0.77/g difference doesn't explain that gap — Rhode Island's chronic under-licensing (8 stores for years) does. Maine's full retail network with zero unlicensed storefronts is the variable.

Tax Structure

Maine uses a two-tier system that is simpler than most states and notably non-compounding:

• Per-pound excise tax at cultivation: $335/lb ($0.74/g) for flower
• 10% retail sales tax (plus up to 3% local option)
• Combined effective burden: ~18.7%

The excise applies at cultivation and the sales tax at retail — they don't stack on each other the way California's multi-tier structure does. The wholesale excise is embedded in the retail price rather than itemized on receipts, so consumers see a clean 10% sales tax line rather than a compounding burden. This structural simplicity likely contributes to Maine's lower effective burden relative to states with similar or lower headline rates.

Total Addressable Market and the Tourism Correction

Maine's adult population is approximately 1.09 million. Applying the empirically validated consumption baseline of 18% participation at 1.0 gram per day:

• 1.09 million adults 21+
• 196,200 estimated regular consumers (18%)
• 71.6 million grams annual resident demand
• Resident TAM at $6.38/g: ~$457 million

Actual 2024 adult-use revenue was $243.9M against that resident TAM — but combined with medical ($269M), total legal cannabis market revenue was $512.9M. The apparent 114% capture requires explanation.

The explanation is 13 million annual overnight tourists. Maine's seasonal visitation pattern is clearly visible in the OCP's monthly data: summer months (June–September) run 35–40% above the winter baseline of stable resident demand. December runs 48–61% above baseline. January and February track close to the winter floor.

Stripping out the non-resident component — estimated at 12.5% of total sales, or approximately $64 million annually — resident capture lands at 100%. The remaining $64M is structurally sustainable tourist and cross-border spending, primarily from Maine's 280-mile border with New Hampshire, where adult-use remains prohibited.

Why this matters for other small tourist states: The same inflation that makes Maine look like a 114% capture market would affect Montana, Vermont, or any jurisdiction where seasonal visitors meaningfully exceed the resident population. Hawaii's market analysis illustrates the inverse problem — overestimating how much tourism drives capture in a medical-only program where the structural barriers prevent tourists from participating at scale. Maine's data provides the corrective: tourism is real and measurable through seasonality, but it needs to be isolated before drawing conclusions about resident demand.

Revenue Trend

Maine's adult-use market is approaching the same plateau pattern as Oregon and Colorado — growth is now driven entirely by volume increases as prices compress, not by new consumer acquisition. The OCP has characterized the flattening as a sign of market maturity and mild oversaturation. At 179 stores for 196,200 estimated consumers, Maine has roughly 1,096 consumers per store — above Oregon's 767 and a reasonable utilization level.

Dispensary Density

Maine's $2.87M per-store revenue lands between Oregon's unsustainable $1.20M and Massachusetts's margin-compressed $4.07M — a reasonable position for a market where 56% of stores serve rural counties. The geographic distribution is notable: Maine places dispensaries throughout its geography, including remote counties with fewer than 20,000 residents. This statewide access is a primary reason full capture is achievable at $7.57/g — consumers in rural Maine can access legal cannabis without significant inconvenience, removing the geographic advantage that sustains unlicensed markets in states like California.

Home Cultivation

Maine law allows adults 21+ to cultivate 6 mature plants plus 12 immature plants per household — among the more permissive home grow policies in the dataset. Despite these rights and prices at the upper end of the full-capture range, participation rates are negligible across every market. Maine's outdoor growing climate limits harvests to fall months, and the legal retail network provides the quality assurance and product variety that makes commercial cultivation economically rational for the vast majority of consumers. Home grow has had no measurable impact on Maine's revenue trajectory.

What the CHS Literature Missed

Maine has an unusually layered consumer health infrastructure for a small-population state: the Maine CDC cannabis page, the OCP-required dispensary prevention sign, and the state-funded Good to Know Maine consumer campaign. All three cover youth brain development, pregnancy, driving impairment, accidental ingestion, and safe storage. None of them mention CHS by name.

Good to Know Maine's safe use page does list "severe nausea/vomiting" among the symptoms of taking too much cannabis — but frames it as a general overconsumption effect, not a distinct syndrome associated with chronic heavy use. The OCP's required dispensary signage covers seven consumer safety topics. CHS is not one of them.

The only Maine source that names CHS directly is a hospital news report describing it as a "rare, serious condition" linked to heavy cannabis use — the same characterization that emerged from the University of Illinois Chicago research cited in the Illinois analysis. Maine's official consumer health infrastructure, across three separate channels covering an estimated 196,200 regular consumers, treats vomiting as an overconsumption symptom rather than a syndrome warranting its own disclosure. That framing is consistent with what population-level behavioral analysis shows about actual CHS prevalence among regular consumers.

The Bottom Line

Maine is the proof that full capture isn't exclusively a function of price. At $7.57/g out the door — above Rhode Island, above Nevada, at the upper edge of the black market range — Maine achieves complete resident displacement through statewide retail access, functional enforcement, and zero unlicensed storefronts. Rhode Island sits 77 cents per gram cheaper and captures 39%.

The tourism data is the other lesson. 13 million annual overnight visitors create a real and measurable non-resident sales component — visible in seasonal spikes of 35–48% above the winter baseline — that inflates aggregate capture figures for any small-population state with heavy visitation. The correct resident capture calculation strips that out. What remains is 100% — and the mechanism is geography and enforcement, not price.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.